Bellicum Pharmaceuticals Profit Margin

Bellicum Pharmaceuticals (BLCM) currently reports a profit margin of -1445.42% as of September 2023. That compares with -1025.33% in the prior-year period — down 41.0% year over year. That is below the Healthcare sector average of 21.34%. Use the charts on this page to explore Bellicum Pharmaceuticals's profit margin history and peer comparisons.

Bellicum Pharmaceuticals's profit margin decreased from -1025.33% to -1445.42% — a 41.0% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellicum Pharmaceuticals's profit margin of -1445.42% is lower than the Healthcare sector average of 21.34%. That is roughly 6874.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Bellicum Pharmaceuticals's current -1445.42% should be judged against Healthcare norms (sector average: 21.34%) and against BLCM's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -1445.42%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.34%. From there, open related valuation or income-statement pages for Bellicum Pharmaceuticals, and consider following BLCM for alerts when major investors trade the stock.